Role of phosphatidylinositol 4,5-bisphosphate in Ras/Rac-induced disruption of the cortactin-actomyosin II complex and malignant transformation
- Author(s)
- He, H; Watanabe, T; Zhan, X; Huang, C; Schuuring, E; Fukami, K; Takenawa, T; Kumar, CC; Simpson, RJ; Maruta, H;
- Details
- Publication Year 1998-07,Volume 18,Issue #7,Page 3829-3837
- Journal Title
- MOLECULAR AND CELLULAR BIOLOGY
- Publication Type
- Journal Article
- Abstract
- Oncogenic Pas mutants such as v-Ha-Ras cause a rapid rearrangement of actin cytoskeleton during malignant transformation of fibroblasts or epithelial cells. Both PI-3 kinase and Pac are required for Ras-induced malignant transformation and membrane ruffling. However, the signal transduction pathway(s) downstream of Rac that leads to membrane ruffling and other cytoskeletal change(s) as well as the exact biochemical nature of the cytoskeletal change remain unknown. Cortactin/EMS1 is the first identified molecule that is dissociated in a Rac-phosphatidylinositol 4,5-biphosphate (PIP2)-dependent manner from the actin-myosin II complex during Pas-induced malignant transformation; either the PIP2 binder HS1 or the Pac blocker SCH51344 restores the ability of EMS1 to bind the complex and suppresses the oncogenicity of Pas. Furthermore, while PIP2 inhibits the actin-EMS1 interaction, HS1 reverses the PIP2 effect. Thus, we propose that PIP2, an end-product of the oncogenic Ras/PI-3 kinase/Rac pathway, serves as a second messenger in the Ras/Rac-induced disruption of the actin cytoskeleton and discuss the anticancer drug potential of PIP2-binding molecules.
- Publisher
- AMER SOC MICROBIOLOGY
- Keywords
- MYOSIN HEAVY-CHAIN; HEMATOPOIETIC LINEAGE; RAS TRANSFORMATION; TYROSINE KINASE; ALPHA-ACTININ; PROTEIN; CELLS; SEQUENCE; BINDING; CDNA
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 1998-07-01 12:00:00